Company intelligence / Profile preview

Endovastec

Shanghai, Shanghai, Chinaendovastec.com ↗

Ownership: Private
Employees: ~1000
Development stage: Commercial

Overview

Endovastec has launched multiple innovative aortic and peripheral vascular intervention devices, including thoracic and abdominal aortic stent grafts, drug-coated PTA balloon catheters, mechanical thrombectomy catheters, and more. Several products have received special regulatory review in China for innovation. The company’s Cratos™ Thoracic Branch Stent Graft System achieved EU Custom-Made Device certification in 2024. Clinical academic articles on key products have been published internationally.

Therapeutic areas: OncologyCardiovascular
Modalities: Device (including stent grafts, balloon catheters, thrombectomy catheters)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Endovastec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endovastec.

Explore the full profile